Buprenorphine Tablet
Product Images NDC 58118-0501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-0501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

FDA Label Image

Image (Buprenorphine 02)

FDA Label Image

Buprenorphine Sl 2mg Tablet 30 Ct Blister Card (Buprenorphine 03)

Buprenorphine Sl 2mg Tablet 30 Ct Blister Card (Buprenorphine 03)
This is a medication information for a product called Buprenorphine HCL. It comes in the form of sublingual tablets with a strength of 2 mg. The medication is manufactured by Rhodes Pharmaceuticals with an expiration date in August 2023, and it is re-packed and distributed by Ol Sltons Whoesal, LLC. The location of the distributor is at 416 My Lintsay Pl 9, S 519 Pl - TN 37067 USA Lo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.